2020-12-04 16:06:56 FATE Fate Therapeutics
12/04/20 12/0416:06 12/04/2016:06 | Fate Therapeutics reports 'positive' ph1 trial data for FT516 in B-cell lymphomaFate Therapeutics announced positive interim data from the company's dose escalation Phase 1 study of FT516 in combination with rituximab for patients with relapsed / refractory B-cell lymphoma. FT516 is the Company's universal, off-the-shelf natural killer cell product candidate derived from a clonal master induced pluripotent stem cell line engineered with a novel high-affinity, non-cleavable CD16 Fc receptor, which is designed to maximize antibody-dependent cellular cytotoxicity . As of a November 16, 2020 data cutoff, three patients in the second dose cohort of 90 million cells per dose and one patient in the third dose cohort of 300 million cells per dose were available for assessment of safety and efficacy. All four patients were heavily pre-treated, having received at least two prior rituximab-containing regimens. Each patient received two 30-day treatment cycles, with each cycle consisting of fludarabine and cyclophosphamide lympho-conditioning followed by three once-weekly doses of FT516, IL-2 cytokine support, and rituximab. Three of four relapsed / refractory patients achieved an objective response, including two complete responses (CR), following the second FT516 treatment cycle as assessed by PET-CT scan per Lugano 2014 criteria. A CR was achieved in one patient with diffuse large B-cell lymphoma (DLBCL) who was most recently refractory to a rituximab-containing treatment regimen, and a CR was achieved in one patient with follicular lymphoma who had previously been treated with four rituximab-containing treatment regimens. Notably, in one patient for which an interim tumor assessment showed a partial response following the first FT516 treatment cycle, the response deepened to a CR following administration of the second FT516 treatment cycle, suggesting that additional FT516 treatment cycles can confer clinical benefit. CEO Scott Wolchko states: "The safety profile of FT516 continues to suggest multiple doses of iPSC-derived NK cells can be administered in the outpatient setting, and supports potential use across multiple lines of therapy, including as part of early-line CD20-targeted monoclonal antibody regimens, for the treatment of B-cell lymphoma." |
|
---|
Recommendations
|
Boston Scientific price target raised by $5 at Mizuho, here's why »
06:37
04/25/24
04/25
06:37
04/25/2406:37
BSX
Boston Scientific
Mizuho raised the… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Earnings
|
Applied Industrial Technologies reports Q3 EPS $2.48, consensus $2.40 »
06:37
04/25/24
04/25
06:37
04/25/2406:37
AIT
Applied Industrial Technologies
Reports Q3 revenue $1.1B,… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Earnings
|
Caterpillar reports Q1 adjusted EPS $5.60, consensus $5.14 »
06:37
04/25/24
04/25
06:37
04/25/2406:37
CAT
Caterpillar
Reports Q1 revenue… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Recommendations
|
Knight-Swift price target lowered by $4 at Baird, here's why »
06:37
04/25/24
04/25
06:37
04/25/2406:37
KNX
Knight-Swift
Baird lowered the… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Recommendations
|
Simmons First National price target lowered by $1 at Stephens, here's why »
06:36
04/25/24
04/25
06:36
04/25/2406:36
SFNC
Simmons First National
Stephens analyst Matt… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Earnings
|
Mobileye sees 2024 revenue $1.83B-$1.96B, consensus $1.9B »
06:36
04/25/24
04/25
06:36
04/25/2406:36
MBLY
Mobileye
Sees 2024 adjusted… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Earnings
|
PG&E backs FY24 core EPS view $1.33-$1.37, consensus $1.35 »
06:36
04/25/24
04/25
06:36
04/25/2406:36
PCG
PG&E
The company said,… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Recommendations
|
Idex Corp. price target lowered by $4 at Baird, here's why »
06:36
04/25/24
04/25
06:36
04/25/2406:36
IEX
Idex Corp.
Baird lowered the… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Recommendations
|
GE Aerospace price target raised by $65.57 at Citi, here's why »
06:36
04/25/24
04/25
06:36
04/25/2406:36
GE
GE Aerospace
Citi raised the… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Earnings
|
Lazard reports Q1 adjusted EPS 66c, consensus 51c »
06:36
04/25/24
04/25
06:36
04/25/2406:36
LAZ
Lazard
Reports Q1 revenue $765M,… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Earnings
|
Mobileye reports Q1 adjusted EPS (7c), consensus (6c) »
06:35
04/25/24
04/25
06:35
04/25/2406:35
MBLY
Mobileye
Reports Q1 revenue $239M,… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Earnings
|
PG&E reports Q1 EPS 37c, consensus 35c »
06:35
04/25/24
04/25
06:35
04/25/2406:35
PCG
PG&E
"Our focus on safety… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
General news
| Oil Action: oil prices… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Recommendations
|
Chipotle price target raised by $40 at Stephens, here's why »
06:33
04/25/24
04/25
06:33
04/25/2406:33
CMG
Chipotle
Stephens analyst Jim… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Recommendations
|
Meta Platforms price target lowered by $80 at KeyBanc, here's why »
06:33
04/25/24
04/25
06:33
04/25/2406:33
META
Meta Platforms
KeyBanc lowered the… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Recommendations
|
Avery Dennison price target raised by $15 at Baird, here's why »
06:33
04/25/24
04/25
06:33
04/25/2406:33
AVY
Avery Dennison
Baird raised the… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Recommendations
|
Meta Platforms price target lowered by $35 at UBS, here's why »
06:33
04/25/24
04/25
06:33
04/25/2406:33
META
Meta Platforms
UBS analyst Lloyd… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Hot Stocks
|
Perrigo to sell HRA Pharma Rare Diseases business for EUR 275M »
06:33
04/25/24
04/25
06:33
04/25/2406:33
PRGO
Perrigo
Perrigo announced that… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Recommendations
|
General Dynamics price target raised by $20 at Citi, here's why »
06:33
04/25/24
04/25
06:33
04/25/2406:33
GD
General Dynamics
Citi raised the… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Earnings
|
Textron reports Q1 adjusted EPS $1.20, consensus $1.13 »
06:33
04/25/24
04/25
06:33
04/25/2406:33
TXT
Textron
Reports Q1 revenue… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Recommendations
|
Vertiv Holdings price target raised by $8 at Citi, here's why »
06:32
04/25/24
04/25
06:32
04/25/2406:32
VRT
Vertiv Holdings
Citi raised the… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Recommendations
|
Amphenol price target raised by $1 at Baird, here's why »
06:32
04/25/24
04/25
06:32
04/25/2406:32
APH
Amphenol
Baird analyst Luke Junk… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Recommendations
|
Meta Platforms price target lowered by $25 at Bernstein, here's why »
06:32
04/25/24
04/25
06:32
04/25/2406:32
META
Meta Platforms
Bernstein lowered the… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Earnings
|
Merck raises FY24 adjusted EPS view to $8.53-$8.65 from $8.44-$8.59 »
06:32
04/25/24
04/25
06:32
04/25/2406:32
MRK
Merck
FY24 consensus $8.56.… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |
Hot Stocks
|
Dow Inc. says demand trending sequentially higher »
06:31
04/25/24
04/25
06:31
04/25/2406:31
DOW
Dow Inc.
The company said,… Available to The Fly Members Only Breaking content available to members only. Sign up or login for access. Create FREE Account |